The UK’s drug regulator, the MHRA, has taken a hit in terms of capacity and funding post-Brexit, and could benefit…
“In a report published earlier this month, the Nuffield Trust warned that drug shortages were a “new normal” in Britain…
A network of countries and health agencies will coordinate a strategy to identify and mitigate future disease threats. Read More
‘The medicines supply chain is broken at every level,’ warns Dr Leyla Hannbeck Read More
“Since leaving the EU in 2020, shortages have become the ‘new normal’.” https://news.sky.com/story/brexit-has-made-uk-medicine-shortages-worse-research-suggests-13117617
Read More Sevington site was never designed to handle the volume of imports envisaged by post-Brexit changes due in April,…
“Experts point to various factors: weakening regulatory focus, a weakening of standards in importation checks post-Brexit and local authority cuts.”…
The UK Medicines and Healthcare products Regulatory Agency (MHRA) recently approved Amgen’s bone cancer drug Xgeva (denosumab), the first drug … Read…
“The Association of Dental Groups has issued a ‘Brexit warning’ for dentistry in 2023 following the publication of Health and…
“Good luck NHS nurses, you need it.” https://leftfootforward.org/2024/01/brexit-and-cost-of-living-crisis-force-spanish-nhs-workers-to-abandon-britain/